Compass Therapeutics Inc. Financial Flexibility Index
Compass Therapeutics Inc. financial flexibility index. Compass Therapeutics Inc. (CMPX) has a Financial Flexibility Index of -0.55x as of June 2026. Free cash flow of $-13.24 Million (operating CF $-13.42 Million minus capex $176.00K) represents -1% of total liabilities ($24.12 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Compass Therapeutics Inc. (2018–2025)
Financial flexibility index of Compass Therapeutics Inc. from 2018 to 2025. Historical Financial Flexibility Index trend for Compass Therapeutics Inc. across 8 annual periods. Explore how well can Compass Therapeutics Inc. service its debt to assess how comfortably operating cash covers total debt obligations.
Compass Therapeutics Inc. Financial Flexibility Index by Year (2018–2025)
Compass Therapeutics Inc. financial flexibility index by year from 2018 to 2025. Year-by-year free cash flow to debt coverage for Compass Therapeutics Inc.. For the full cash flow conversion analysis, see CMPX operating cash flow.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.15x | $-49.12 Million | $-49.14 Million | $22.80 Million | ▲ +27.1% |
| 2024 | -2.95x | $-44.81 Million | $-44.85 Million | $15.17 Million | ▲ +39.3% |
| 2023 | -4.87x | $-40.59 Million | $-40.62 Million | $8.34 Million | ▼ -158.5% |
| 2022 | -1.88x | $-33.91 Million | $-34.12 Million | $18.01 Million | ▼ -42.3% |
| 2021 | -1.32x | $-18.10 Million | $-19.67 Million | $13.68 Million | ▲ +40.7% |
| 2020 | -2.23x | $-26.70 Million | $-26.80 Million | $11.97 Million | ▼ -962.8% |
| 2019 | -0.21x | $-31.27 Million | $-31.74 Million | $148.98 Million | ▲ +0.9% |
| 2018 | -0.21x | $-31.66 Million | $-33.68 Million | $149.40 Million | — |